Lupin, its JV submit new drug application for Etanercept biosimilar in Japan
Drug firm Lupin today said its Japanese arm and
Lupin MD Nilesh Gupta said: "The application for Etanercept biosimilar is a significant milestone for Lupin as we build our biosimilars pipeline."
Disclaimer: No Business Standard Journalist was involved in creation of this content